Best practice

Compliance controls against corruption

Corrupt activities in low- and middle-income markets risk progress toward meeting the 2030 Sustainable Development Goals and Universal Health Coverage target.

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |